RSV Bivalent Prefusion F Protein Vaccine in Pregnancy

Дата публикации: 08-09-2026 00:00:00

This systematic review and meta-analysis investigates if the respiratory syncytial virus (RSV) bivalent prefusion F protein vaccine administered during pregnancy protects infants against RSV-associated lower respiratory tract infection hospitalization in real-world settings.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Maternal Vaccine Effectiveness Against Influenza in Infants	0	10.36	01-02-2024
2	GSK’s RSV vaccine, Arexvy, receives European approval for expanded use in all adults 18 years and older	0	17.58	26-01-2026
3	HPV Vaccine May Have Benefits Beyond Cancer Protection	0	10.42	08-10-2026
4	A Plea for Intravenous Iron in Pregnancy—Delivering Results	0	10	23-09-2026
5	Depression and SSRI Treatment During Pregnancy	0	8.77	01-10-2026
6	Врач объяснил, можно ли вакцинироваться во время или после болезни	0	7.37	06-10-2026
7	Cristina Longo: targeting asthma treatment from pregnancy	0	10	13-08-2026
8	GSK’s RSV vaccine, Arexvy, approved in US for expanded age indication in adults aged 18–49 years at increased risk	0	12.43	13-03-2026
9	В России разработали метод оценки риска осложнений беременности после COVID-19	0	7.87	30-09-2026
10	Attention au vapotage durant la grossesse!	0	11.3	08-09-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 11.82. Источник: jamanetwork.com.